Home Cart Sign in  
Chemical Structure| 1383716-40-2 Chemical Structure| 1383716-40-2

Structure of Vps34-PIK-III
CAS No.: 1383716-40-2

Chemical Structure| 1383716-40-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

PIK-III, which is a selective inhibitor of ​VPS34 enzymatic activity, inhibits autophagy and de novo lipidation of LC3 and leads to the stabilization of autophagy substrates.

Synonyms: PIK-III; Vacuolar Protein Sorting 34 Inhibitor 2; Vps34 Inhibitor 2

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Vps34-PIK-III

CAS No. :1383716-40-2
Formula : C17H17N7
M.W : 319.36
SMILES Code : NC1=NC=C(C2=NC(NC3=CC=NC=C3)=NC=C2)C(CC4CC4)=N1
Synonyms :
PIK-III; Vacuolar Protein Sorting 34 Inhibitor 2; Vps34 Inhibitor 2
MDL No. :MFCD28963904
InChI Key :XXSDLQLNIVFIJI-UHFFFAOYSA-N
Pubchem ID :67983123

Safety of Vps34-PIK-III

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Vps34-PIK-III

PI3K-AKT

Isoform Comparison

Biological Activity

Target
  • p110δ

    PI3Kδ, IC50:1.2μM

  • Vps34

    Vps34, IC50:0.018μM

In Vitro:

Cell Line
Concentration Treated Time Description References
Huh7 cells 5 μM 24 hours Vps34-PIK-III significantly decreased the expression of stemness genes and induced AMPK activation. PMC7280510
MHCC97H cells 5 μM 24 hours Vps34-PIK-III significantly decreased the expression of stemness genes and induced AMPK activation. PMC7280510

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Nude mice RKO colon cancer tumor model Oral 50 mg/kg Twice a day for 7 days To evaluate the ability of compound 19 to inhibit autophagy in vivo, results showed accumulation of LC3-II indicating reduced autophagic capacity. PMC4716600

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.13mL

0.63mL

0.31mL

15.66mL

3.13mL

1.57mL

31.31mL

6.26mL

3.13mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories